{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:47:17Z","timestamp":1788461237116,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.cancergencyto.2005.06.002","type":"journal-article","created":{"date-parts":[[2005,11,5]],"date-time":"2005-11-05T12:38:03Z","timestamp":1131194283000},"page":"62-67","source":"Crossref","is-referenced-by-count":35,"title":["CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity"],"prefix":"10.1016","volume":"163","author":[{"given":"Igor","family":"Kozlov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Beason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hughson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.06.002_bib1","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Acute myeloid leukemias. Chapter 4. In: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. Lyon: IARC Press, 2001, pp. 75\u2013107."},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.1998.00523.x","article-title":"Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression","volume":"100","author":"Legrand","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib3","first-page":"1783","article-title":"European Group for the Immunological Characterization of Leukemias (EGIL). Proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib4","first-page":"1283","article-title":"Cytogenetic findings in acute biphenotypic leukaemia","volume":"10","author":"Carbonell","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajh.1155","article-title":"Flow cytomentric analysis of cell-surface antigen in the diagnosis of acute leukemia","volume":"68","author":"Paredes-Aguilera","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1309\/391R-93YF-DB4D-1L35","article-title":"Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias","volume":"113","author":"Lai","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood.V82.3.853.bloodjournal823853","article-title":"mb-1: a new marker for B-lineage lymphoblastic leukemia","volume":"82","author":"Buccheri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5858\/2003-127-0356-BALWCO","article-title":"Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage","volume":"127","author":"Frater","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib9","first-page":"699","article-title":"Outcome of biphenotypic leukemia","volume":"84","author":"Killick","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/10428190412331272730","article-title":"Biphenotypic acute leukemia with t(15;17)","volume":"46","author":"Scolnik","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood.V81.4.883.883","article-title":"Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1\/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia","volume":"81","author":"Nucifora","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib12","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1182\/blood.V91.9.3134","article-title":"Expression of a knocked-in AML1\u2013ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors","volume":"91","author":"Okuda","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib13","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/MCB.15.4.1974","article-title":"The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation","volume":"15","author":"Meyers","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V99.1.15","article-title":"The AML1\u2013ETO fusion protein promotes the expansion of human hematopoietic stem cells","volume":"99","author":"Mulloy","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib15","doi-asserted-by":"crossref","first-page":"14059","DOI":"10.1073\/pnas.93.24.14059","article-title":"The AML1\/ETO fusion protein activates transcription of BCL-2","volume":"93","author":"Klampfer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0609.1991.tb00556.x","article-title":"Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL)","volume":"47","author":"Johansson","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/1097-0142(19900315)65:6<1350::AID-CNCR2820650617>3.0.CO;2-J","article-title":"The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication","volume":"65","author":"Horiike","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2005.06.002_bib18","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of cytogenetics on outcome in AML: an analysis of 1,612 patients entering into the MRC AML 10 trial","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805003006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805003006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T06:59:54Z","timestamp":1626677994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805003006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0165460805003006"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.06.002","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}